✦ LIBER ✦

Rituximab (anti-CD20 monoclonal antibody) as consolidation of first-line CHOP chemotherapy in patients with follicular lymphoma: a phase II study

✍ Scribed by Gerald Jäeger; Peter Neumeister; Ruth Brezinschek; Gerald Höfler; Franz Quehenberger; Werner Linkesch; Heinz Sill

Book ID: 114423132
Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 121 KB
Volume: 69
Category: Article
ISSN: 0902-4441
DOI: 10.1034/j.1600-0609.2002.01692.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CHOP chemotherapy followed by Rituximab

CHOP chemotherapy followed by Rituximab consolidation as first line treatment in patients with follicular lymphoma. Long-term follow-up of a phase 2 trial

✍ Gerald Jäger; Franz Quehenberger; Werner Linkesch; Peter Neumeister 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 441 KB

IDEC-C2B8 (Rituximab) anti-CD20 antibody

IDEC-C2B8 (Rituximab) anti-CD20 antibody treatment in relapsed advanced-stage follicular lymphomas: results of a phase-II study of the German Low-Grade Lymphoma Study Group

✍ M. Feuring-Buske; M. Kneba; M. Unterhalt; A. Engert; M. Gramatzki; E. Hiller; L. 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 90 KB

Long-term update of a phase II study of

Long-term update of a phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma

✍ Vose, J. M.; Link, B. K.; Grossbard, M. L.; Czuczman, M.; Grillo-Lopez, A.; Fish 📂 Article 📅 2005 🏛 Informa plc 🌐 English ⚖ 205 KB

Rituximab plus Short-Duration Chemothera

Rituximab plus Short-Duration Chemotherapy Followed by Yttrium-90 Ibritumomab Tiuxetan as First-Line Treatment for Patients with Follicular Non-Hodgkin Lymphoma: A Phase II Trial of the Sarah Cannon Oncology Research Consortium

✍ Hainsworth, John D.; Spigel, David R.; Markus, Tiffanie M.; Shipley, Dianna; Tho 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 121 KB

Rituximab Maintenance Compared With Obse

Rituximab Maintenance Compared With Observation After Brief First-Line R-FND Chemoimmunotherapy With Rituximab Consolidation in Patients Age Older Than 60 Years With Advanced Follicular Lymphoma: A Phase III Randomized Study by the Fondazione Italiana Linfomi

✍ Vitolo, U.; Ladetto, M.; Boccomini, C.; Baldini, L.; De Angelis, F.; Tucci, A.; 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 215 KB

A phase II study of docetaxel and cispla

A phase II study of docetaxel and cisplatin as first-line chemotherapy in patients with metastatic nasopharyngeal carcinoma

✍ Daniel T.T. Chua; Jonathan S.T. Sham; Gordon K.H. Au 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 110 KB